Across TCGA pan-cancer cohorts, ZNF965P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated ZNF965P data layer.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher ZNF965P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ZNF965P expression acts as an unfavorable survival marker.
LUSC, STAD, and OV are the cancer types where ZNF965P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.